Similar companies
Income Statement (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Gross Profit | -1.3M | 13% |
| Cost of Revenue | 1.3M | 13% |
| Operating expense | 2.6M | 13.3% |
| Net Income | -2.1M | 13.2% |
Balance Sheet (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Total Assets | 3M | 42.1% |
| Total Liabilities | 3.7M | 3.9% |
| Shares Outstanding | 3.7M | 62.5% |
Cash Flow (USD)
| Q3 '24 | QoQ | |
|---|---|---|
| Cash from operations | -2.7M | 37.5% |
| Cash from financing | -16,000 | 100.2% |
EPS
Financial Highlights for Bio Path Holdings in Q3 '24
Gross Profit stood at -1.3M, marking a -13% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 1.3M, a 13% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 2.6M, showing a -13.3% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -2.1M, showing a -13.2% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
Bio Path Holdings faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. An increase in the cost of revenue, higher than the revenue growth, suggests potential margin pressures.
